{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:32:20Z","timestamp":1794641540229,"version":"4.9.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec id=\"ab-eoi250064-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Retinal capillary nonperfusion seems crucial in the pathogenesis of sight-threatening diabetic retinopathy (DR); currently, no treatment prevents or reverts it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250064-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To further the understanding of the association between retinal capillary nonperfusion and sensitivity in DR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250064-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective, longitudinal cohort study was conducted from April 18, 2018, to September 9, 2024, at a single center in the UK. Participants were followed up for up to 2 years; outcome assessors were masked. Adults (aged \u226518 years) with moderate or severe to very severe nonproliferative or proliferative DR with less than high-risk characteristics; at least 1 eye naive to treatment; no other retinal disorders; who were able to provide informed consent; and who were willing undergo retinal imaging were eligible for inclusion. Data analysis was performed from September 2024 to April 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250064-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the association between retinal sensitivity (110\u00b0 projection perimetry) and retinal perfusion (ultra-widefield angiography) at baseline and changes at 1 and 2 years in the study eye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250064-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 66 people approached, 50 were eligible and recruited, and 44 individuals with at least 1 perimetric examination were included. Mean (SD) participant age was 52.1 (12.2) years, and 13 participants (29%) were female. Median hemoglobin A\n                      <jats:sub>\n                        1\n                        <jats:sc>c<\/jats:sc>\n                      <\/jats:sub>\n                      was 75.5 mmol\/mol (9.1% of total hemoglobin [to convert from percentage of total hemoglobin to proportion of total hemoglobin, multiply by 0.01]); mean (SD) best-corrected visual acuity letter score was 85.7 (4.7) (Snellen equivalent, 20\/20). Mean retinal sensitivity deficit at baseline was associated with perfusion status, with larger deficits in nonperfused areas (n\u2009=\u2009354; 11.8 dBs; 95% CI, 10.8-12.8) compared to perfused areas (n\u2009=\u20092092; 6.6 dB; 95% CI, 5.1-8.2;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Only age correlated positively with sensitivity deficit (estimate, 0.2; 95% CI, 0.1-0.3;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.006). A deficit of 5 dB or greater occurred in 711 of 2092 (34%) perfused areas; 105 of 354 (30%) nonperfused areas had normal sensitivity. Rates of sensitivity deficit change in perfused and nonperfused areas from baseline to 1 year were \u22120.20 dB\/mo (95% CI, \u22120.24 to \u22120.16) and \u22120.28 dB\/mo (95% CI, \u22120.41 to \u22120.15) (perfused vs nonperfused,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.22), respectively (1464 areas); from baseline to 2 years, rates were \u22120.16 dB\/mo (95% CI, \u22120.20 to \u22120.12) and \u22120.34 dB\/mo (95% CI, \u22120.47 to \u22120.21) (perfused vs nonperfused,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.007), respectively (542 areas).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250064-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this longitudinal cohort study, although retinal capillary perfusion status was associated with function, sensitivity loss occurred in some perfused areas and normal function in some nonperfused areas; sensitivity deficit decreased over time (approximately 45% in the first year) despite poor glycemic control and high DR grades. These findings should be considered for the management of people with DR and the design of clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2025.3980","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T15:31:40Z","timestamp":1761838300000},"page":"91","source":"Crossref","is-referenced-by-count":1,"title":["Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy"],"prefix":"10.1001","volume":"144","author":[{"given":"Jennifer A.","family":"Hamilton-Perais","sequence":"first","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Wright","sequence":"additional","affiliation":[{"name":"The Centre for Public Health Queen\u2019s University Belfast, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Lim","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, Northern Ireland, United Kingdom"},{"name":"The Gleneagles Hospital Penang, Penang, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Mohite","sequence":"additional","affiliation":[{"name":"The Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom"},{"name":"The Royal Free London Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Reid","sequence":"additional","affiliation":[{"name":"The Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearse","family":"Hillis","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Sheeran","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Lois","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast, Northern Ireland, United Kingdom"},{"name":"The Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"eoi250064r1","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/jcm12062406","article-title":"Retinal ischaemia in diabetic retinopathy: understanding and overcoming a therapeutic challenge.","volume":"12","author":"Mohite","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"eoi250064r2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2022.3130","article-title":"Association of ultra-widefield fluorescein angiography\u2013identified retinal nonperfusion and the risk of diabetic retinopathy worsening over time.","volume":"140","author":"Silva","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"eoi250064r3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis.","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi250064r4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamaophthalmol.2022.5817","article-title":"Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis.","volume":"141","author":"McCullough","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi250064r5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review.","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"eoi250064r8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archopht.1984.01040031044020","article-title":"Retinal microangiopathy. correlation of OCTOPUS perimetry with fluorescein angiography.","volume":"102","author":"Bell","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi250064r10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1755-3768.1990.tb01670.x","article-title":"Coexistence of localized scotomata and neovascularizations in proliferative diabetic retinopathy.","volume":"68","author":"Bek","year":"1990","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"eoi250064r11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1755-3768.1991.tb01984.x","article-title":"Localised scotomata and types of vascular occlusion in diabetic retinopathy.","volume":"69","author":"Bek","year":"1991","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"11","key":"eoi250064r12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bjo.77.11.726","article-title":"Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy.","volume":"77","author":"Chee","year":"1993","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi250064r13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajo.2007.07.011","article-title":"Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy.","volume":"144","author":"Unoki","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"eoi250064r14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.62.14.28","article-title":"Retinal sensitivity correlates with the superficial vessel density and inner layer thickness in diabetic retinopathy.","volume":"62","author":"Mokrane","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi250064r15","first-page":"358","article-title":"Automated static perimetry to evaluate diabetic retinopathy.","volume":"82","author":"Federman","year":"1984","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"eoi250064r16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1006024305992","article-title":"Automated static perimetry as a screening method for evaluation of retinal perfusion in diabetic retinopathy.","volume":"21","author":"Pahor","year":"1997","journal-title":"Int Ophthalmol"},{"key":"eoi250064r17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2023.09.007","article-title":"Topographic correlation of microperimetry with structural characteristics in diabetic macular ischemia.","volume":"257","author":"Tsai","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"eoi250064r18","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/jcm13082219","article-title":"The natural history of retinal sensitivity loss in diabetic macular ischemia over one year evaluated by microperimetry.","volume":"13","author":"Tsai","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"eoi250064r19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.62.1.9","article-title":"Diabetic macular ischemia: influence of optical coherence tomography angiography parameters on changes in functional outcomes over one year.","volume":"62","author":"Tsai","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi250064r20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/IAE.0b013e3182278b64","article-title":"Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy.","volume":"32","author":"Wessel","year":"2012","journal-title":"Retina"},{"issue":"1","key":"eoi250064r21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/OPX.0b013e3181fc3735","article-title":"Imaging and Perimetry Society standards and guidelines.","volume":"88","author":"Sample","year":"2011","journal-title":"Optom Vis Sci"},{"issue":"5","key":"eoi250064r22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs\u2013an extension of the modified Airlie House classification. ETDRS report number 10.","volume":"98","author":"Group","year":"1991","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi250064r26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaophthalmol.2019.5939","article-title":"Visual field changes over 5 years in patients treated with panretinal photocoagulation or ranibizumab for proliferative diabetic retinopathy.","volume":"138","author":"Maguire","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi250064r27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1755-3768.1976.tb01263.x","article-title":"Static perimetry: accuracy and fluctuations.","volume":"54","author":"Bebie","year":"1976","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"3","key":"eoi250064r29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000331418","article-title":"Oxygen sensing in retinal health and disease.","volume":"227","author":"Lange","year":"2012","journal-title":"Ophthalmologica"},{"issue":"5","key":"eoi250064r30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archopht.116.5.589","article-title":"Choriocapillaris degeneration and related pathologic changes in human diabetic eyes.","volume":"116","author":"Cao","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"eoi250064r31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archopht.1989.01070010083032","article-title":"The effect of perimetric experience in normal subjects.","volume":"107","author":"Heijl","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"eoi250064r32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archopht.1996.01100130017003","article-title":"The effect of perimetric experience in patients with glaucoma.","volume":"114","author":"Heijl","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"eoi250064r33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1755-3768.1990.tb01694.x","article-title":"Factors associated with a learning effect in glaucoma patients using automated perimetry.","volume":"68","author":"Kulze","year":"1990","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"eoi250064r34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0161-6420(90)32628-3","article-title":"Effect of patient experience on the results of automated perimetry in glaucoma suspect patients.","volume":"97","author":"Werner","year":"1990","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi250064r35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0161-6420(88)33111-8","article-title":"Effect of patient experience on the results of automated perimetry in clinically stable glaucoma patients.","volume":"95","author":"Werner","year":"1988","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi250064r36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1755-3768.1991.tb02713.x","article-title":"Long-term follow-up of baseline learning and fatigue effects in the automated perimetry of glaucoma and ocular hypertensive patients.","volume":"69","author":"Wild","year":"1991","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"11","key":"eoi250064r37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/OPX.0b013e31818b9b40","article-title":"Is there evidence for continued learning over multiple years in perimetry?","volume":"85","author":"Gardiner","year":"2008","journal-title":"Optom Vis Sci"},{"key":"eoi250064r7","first-page":"25","volume-title":"Visual field in diabetic retinopathy (DR)","author":"Greite","year":"1981"},{"key":"eoi250064r9","first-page":"461","volume-title":"Visual field in diabetic retinopathy\u2014light sensitivity in retinal lesions","author":"Yabuki","year":"1987"},{"key":"eoi250064r6","unstructured":"Diabetes UK. Reducing sight loss in people living with diabetes. Accessed June 3, 2025. https:\/\/www.diabetes.org.uk\/sites\/default\/files\/2022-10\/Reducing%20Sight%20Loss%20in%20People%20Living%20With%20Diabetes%20-%20Highlight%20Notice_0.pdf?VersionId=RllkPfrPceeKet8C9ihjw6e7VIbkzLKa"},{"key":"eoi250064r23","unstructured":"Metrovision. Visual field perimeters: MonCvONE-PRO for standard automated and Goldmann perimetry. Accessed June 3, 2025. https:\/\/metrovision.fr\/perimeters-us.html"},{"key":"eoi250064r24","unstructured":"Optos. California. https:\/\/www.optos.com\/products\/california"},{"key":"eoi250064r25","unstructured":"Optos. Our software products. https:\/\/www.optos.com\/our-software-products\/"},{"key":"eoi250064r28","unstructured":"Metrovision. User\u2019s manual: visual field standard automated perimetry. https:\/\/metrovision.fr\/pdf\/CV_US.pdf"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2840290\/jamaophthalmology_hamiltonperais_2025_oi_250064_1767803520.40278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:01:07Z","timestamp":1768492867000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2840290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.3980","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}